Oral Abstract Session:
33. What's Hot in UTIs and STIs
Thursday, October 4, 2018: 8:45 AM-10:00 AM
Room: S 158

Tracks: Adult ID

Moderators:  Michael T. Melia, MD, Johns Hopkins University School of Medicine and Marisa Holubar, MD, MS, Stanford Health Care

8:45 AM
Microbiological Outcomes With Plazomicin (PLZ) Versus Meropenem (MEM) in Patients (pts) With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis (AP) in the EPIC Study
Tiffany R. Keepers, PhD; Deborah S. Cebrik, MS, MPH; Daniel J. Cloutier, PharmD; Allison Komirenko, PharmD; Lynn Connolly, MD, PhD; Kevin Krause, MBA
9:00 AM
eGISP: Enhanced Surveillance of Neisseria gonorrhoeae Antimicrobial Susceptibility in the United States
Laura Quilter, MD, MPH; Sancta St. Cyr, MD, MPH; Vincent Abitria, BSMT (AMT); Andrew Ancharski, MSPH, MPH; Ilene Bautista, MPH, MLS (ASCP); Jose Bazan, D.O.; Karen Carifo, MSA, PhD; Melissa Ervin, MT (ASCP); Rebecca Harrison, RN; Aaron Hoogenboom, MT (ASCP); Amy Peterson, MPH; Cau Pham, PhD; Brandon Snyder, BS; Abigail Norris Turner, Ph.D.; Elizabeth Torrone, PhD, MSPH
9:15 AM
Robust and Persistent Vaginal Colonization with LACTIN-V Vaginal Lactobacillus crispatus Probiotic in a Double-Blind, Placebo Controlled (DBPC) Phase 2b Trial to Prevent Recurrent UTI (rUTI)
Ann Stapleton, MD, FIDSA; Aurelio Silvestroni, PhD; Pacita Roberts, MS; Marsha Cox, MS; Hillary Hayden, PhD; Mitchell Brittnacher, PhD; Samuel Miller, MD; Thomas Hooton, MD, FIDSA
9:30 AM
Urinary Tract Infection Incidence is Associated with Recent Environmental Temperatures
Jacob Simmering, PhD; Daniel Sewell, PhD; Linnea Polgreen, PhD; Philip M. Polgreen, MD
9:45 AM
Sexually transmitted infections among adolescent girls in Thika, Kenya
Tiffany Yuh, MD; Catherine Kiptinness, MPH; Stacy Selke, MS; Lynda Oluoch, MD; Amalia Magaret, PhD; Kenneth Ngure, MSc, PhD; Anna Wald, MD, MPH, FIDSA; Nelly Mugo, MD; Alison C. Roxby, MD, MSc

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.